ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 3, 2011, Pages 227.e1-227.e6

  Tu, Bin Bin ^a   Lin, Sheng Li ^b   Yan, Li Ying ^a   Wang, Zhao Yi ^c   Sun, Qing Yuan ^b   Qiao, Jie ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b INSTITUTE OF ZOOLOGY   (China)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endometrial cancer; epidermal growth factor receptor; estrogen receptor 36; estrogen receptor 66; MAPK ERK pathway

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 36; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 80052265968     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.04.015     Document Type: Article

References (22)

1. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote Endometrial cancer Lancet 366 2005 491 505 (Pubitemid 41111699)
2. L. Dossus, N. Allen, and R. Kaaks Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition Int J Cancer 127 2010 442 451
3. S.L. Lin, L.Y. Yan, and X.W. Liang A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells Reprod Biol Endocrinol 7 2009 102
4. K. Ejskjaer, B.S. Sorensen, S.S. Poulsen, A. Forman, E. Nexo, and O. Mogensen Expression of the epidermal growth factor system in endometrioid endometrial cancer Gynecol Oncol 104 2007 158 167 (Pubitemid 46054118)
5. Z. Wang, X. Zhang, P. Shen, B.W. Loggie, Y. Chang, and T.F. Deuel Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66 Biochem Biophys Res Commun 336 2005 1023 1027 (Pubitemid 41383424)
6. Z. Wang, X. Zhang, P. Shen, B.W. Loggie, Y. Chang, and T.F. Deuel A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling Proc Natl Acad Sci U S A 103 2006 9063 9068 (Pubitemid 43902533)
7. L. Shi, B. Dong, and Z. Li Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer J Clin Oncol 27 2009 3423 3429
8. S.L. Lin, L.Y. Yan, and X.T. Zhang ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways PLoS One 5 2010 e9013
9. R. Castellani, D.W. Visscher, S. Wykes, F.H. Sarkar, and J.D. Crissman Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma: an immunohistologic study Cancer 73 1994 344 349 (Pubitemid 24030612)
10. D. Torregrosa, P. Bolufer, and A. Lluch Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status Clin Chim Acta 262 1997 99 119 (Pubitemid 27241382)
11. Z. Ai, J. Wang, Y. Wang, L. Lu, J. Tong, and Y. Teng Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway Cancer 116 2010 3603 3613
12. V.M. Jasonni, D. Santini, A. Amadori, C. Ceccarelli, and S. Naldi Epidermal growth factor receptor expression and endometrial cancer histotypes Ann N Y Acad Sci 734 1994 298 305
13. D.M. Ignar-Trowbridge, C.T. Teng, K.A. Ross, M.G. Parker, K.S. Korach, and J.A. McLachlan Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element Mol Endocrinol 7 1993 992 998 (Pubitemid 23252338)
14. S. Kato, H. Endoh, and Y. Masuhiro Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 1995 1491 1494
15. G. Bunone, P.A. Briand, R.J. Miksicek, and D. Picard Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation EMBO J 15 1996 2174 2183 (Pubitemid 26141134)
16. P.B. Joel, J. Smith, T.W. Sturgill, T.L. Fisher, J. Blenis, and D.A. Lannigan pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167 Mol Cell Biol 18 1998 1978 1984 (Pubitemid 28152646)
17. F. Hafner, E. Holler, and E. von Angerer Effect of growth factors on estrogen receptor mediated gene expression J Steroid Biochem Mol Biol 58 1996 385 393 (Pubitemid 26348972)
18. A. Vivacqua, D. Bonofiglio, and A.G. Recchia The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells Mol Endocrinol 20 2006 631 646 (Pubitemid 43291214)
19. L.M. Lee, J. Cao, H. Deng, P. Chen, Z. Gatalica, and Z.Y. Wang ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas Anticancer Res 28 2008 479 483
20. D.J. Mangelsdorf, C. Thummel, and M. Beato The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
21. H. Deng, X. Huang, and J. Fan A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis Oncol Rep 24 2010 171 176
22. G. Birmelin, V. Zimmer, W. Sauerbrei, A. Pfleiderer, and T. Bauknecht Relationship between epidermal growth factor receptor (EGF-R) and various prognostic factors in human endometrial carcinoma Int J Gynecol Cancer 2 1992 66 74